메뉴 건너뛰기




Volumn 13, Issue 1, 2013, Pages

Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines

Author keywords

Bladder; Cancer; Geldanamycin; Hsp90; Signaling

Indexed keywords

GELDANAMYCIN; HEAT SHOCK PROTEIN 90; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; SOMATOMEDIN; TRANSCRIPTION FACTOR FOXO;

EID: 84873432452     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-11     Document Type: Article
Times cited : (33)

References (33)
  • 1
    • 36849056135 scopus 로고    scopus 로고
    • Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex
    • 10.2174/092986707782793925, 18220746
    • Stravopodis DJ, Margaritis LH, Voutsinas GE. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex. Curr Med Chem 2007, 14(29):3122-3138. 10.2174/092986707782793925, 18220746.
    • (2007) Curr Med Chem , vol.14 , Issue.29 , pp. 3122-3138
    • Stravopodis, D.J.1    Margaritis, L.H.2    Voutsinas, G.E.3
  • 2
    • 25844519550 scopus 로고    scopus 로고
    • HSP90 and the chaperoning of cancer
    • 10.1038/nrc1716, 16175177
    • Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005, 5(10):761-772. 10.1038/nrc1716, 16175177.
    • (2005) Nat Rev Cancer , vol.5 , Issue.10 , pp. 761-772
    • Whitesell, L.1    Lindquist, S.L.2
  • 3
    • 0036810352 scopus 로고    scopus 로고
    • Heat-shock protein 90, a chaperone for folding and regulation
    • 10.1007/PL00012491, 12475174
    • Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci 2002, 59(10):1640-1648. 10.1007/PL00012491, 12475174.
    • (2002) Cell Mol Life Sci , vol.59 , Issue.10 , pp. 1640-1648
    • Picard, D.1
  • 4
    • 33846861747 scopus 로고    scopus 로고
    • Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
    • Powers MV, Workman P. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr Relat Cancer 2006, 13(Suppl 1):S125-135.
    • (2006) Endocr Relat Cancer , vol.13 , Issue.SUPPL. 1
    • Powers, M.V.1    Workman, P.2
  • 6
    • 4143095430 scopus 로고    scopus 로고
    • Altered Hsp90 function in cancer: a unique therapeutic opportunity
    • Bagatell R, Whitesell L. Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 2004, 3(8):1021-1030.
    • (2004) Mol Cancer Ther , vol.3 , Issue.8 , pp. 1021-1030
    • Bagatell, R.1    Whitesell, L.2
  • 7
    • 33750710409 scopus 로고    scopus 로고
    • Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy
    • Lattouf JB, Srinivasan R, Pinto PA, Linehan WM, Neckers L. Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy. Nat Clin Pract Urol 2006, 3(11):590-601.
    • (2006) Nat Clin Pract Urol , vol.3 , Issue.11 , pp. 590-601
    • Lattouf, J.B.1    Srinivasan, R.2    Pinto, P.A.3    Linehan, W.M.4    Neckers, L.5
  • 8
    • 35548970287 scopus 로고    scopus 로고
    • Heat shock proteins in cancer
    • 10.1196/annals.1391.030, 17978282
    • Sherman M, Multhoff G. Heat shock proteins in cancer. Ann N Y Acad Sci 2007, 1113:192-201. 10.1196/annals.1391.030, 17978282.
    • (2007) Ann N Y Acad Sci , vol.1113 , pp. 192-201
    • Sherman, M.1    Multhoff, G.2
  • 9
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: the next generation
    • 10.1016/j.cell.2011.02.013, 21376230
    • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
    • (2011) Cell , vol.144 , Issue.5 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 10
    • 35348890981 scopus 로고    scopus 로고
    • Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress
    • 10.1196/annals.1391.012, 17513464
    • Workman P, Burrows F, Neckers L, Rosen N. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 2007, 1113:202-216. 10.1196/annals.1391.012, 17513464.
    • (2007) Ann N Y Acad Sci , vol.1113 , pp. 202-216
    • Workman, P.1    Burrows, F.2    Neckers, L.3    Rosen, N.4
  • 11
    • 34247337239 scopus 로고    scopus 로고
    • Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification
    • 10.1200/JCO.2006.08.2073, 17158541
    • Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 2006, 24(35):5552-5564. 10.1200/JCO.2006.08.2073, 17158541.
    • (2006) J Clin Oncol , vol.24 , Issue.35 , pp. 5552-5564
    • Mitra, A.P.1    Datar, R.H.2    Cote, R.J.3
  • 12
    • 77953853118 scopus 로고    scopus 로고
    • Molecular pathways of urothelial development and bladder tumorigenesis
    • 10.1016/j.urolonc.2009.04.019, 20610278
    • Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 2010, 28(4):401-408. 10.1016/j.urolonc.2009.04.019, 20610278.
    • (2010) Urol Oncol , vol.28 , Issue.4 , pp. 401-408
    • Castillo-Martin, M.1    Domingo-Domenech, J.2    Karni-Schmidt, O.3    Matos, T.4    Cordon-Cardo, C.5
  • 13
    • 59249093638 scopus 로고    scopus 로고
    • Molecular pathogenesis and diagnostics of bladder cancer
    • 10.1146/annurev.pathol.4.110807.092230, 18840072
    • Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol 2009, 4:251-285. 10.1146/annurev.pathol.4.110807.092230, 18840072.
    • (2009) Annu Rev Pathol , vol.4 , pp. 251-285
    • Mitra, A.P.1    Cote, R.J.2
  • 14
    • 21744435151 scopus 로고    scopus 로고
    • Molecular staging of bladder cancer
    • 10.1111/j.1464-410X.2005.05557.x, 15963111
    • Mitra AP, Datar RH, Cote RJ. Molecular staging of bladder cancer. BJU Int 2005, 96(1):7-12. 10.1111/j.1464-410X.2005.05557.x, 15963111.
    • (2005) BJU Int , vol.96 , Issue.1 , pp. 7-12
    • Mitra, A.P.1    Datar, R.H.2    Cote, R.J.3
  • 16
    • 77953847133 scopus 로고    scopus 로고
    • Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression
    • 10.1016/j.urolonc.2010.04.008, 2901550, 20610280
    • McConkey DJ, Lee S, Choi W, Tran M, Majewski T, Lee S, Siefker-Radtke A, Dinney C, Czerniak B. Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression. Urol Oncol 2010, 28(4):429-440. 10.1016/j.urolonc.2010.04.008, 2901550, 20610280.
    • (2010) Urol Oncol , vol.28 , Issue.4 , pp. 429-440
    • McConkey, D.J.1    Lee, S.2    Choi, W.3    Tran, M.4    Majewski, T.5    Lee, S.6    Siefker-Radtke, A.7    Dinney, C.8    Czerniak, B.9
  • 17
    • 77953819013 scopus 로고    scopus 로고
    • Bladder cancer or bladder cancers? genetically distinct malignant conditions of the urothelium
    • 10.1016/j.urolonc.2010.04.003, 20610279
    • Goebell PJ, Knowles MA. Bladder cancer or bladder cancers? genetically distinct malignant conditions of the urothelium. Urol Oncol 2010, 28(4):409-428. 10.1016/j.urolonc.2010.04.003, 20610279.
    • (2010) Urol Oncol , vol.28 , Issue.4 , pp. 409-428
    • Goebell, P.J.1    Knowles, M.A.2
  • 18
    • 84855227050 scopus 로고    scopus 로고
    • Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
    • 10.1038/nrurol.2011.193, 22158597
    • Netto GJ. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?. Nat Rev Urol 2011, 9(1):41-51. 10.1038/nrurol.2011.193, 22158597.
    • (2011) Nat Rev Urol , vol.9 , Issue.1 , pp. 41-51
    • Netto, G.J.1
  • 19
    • 70350042935 scopus 로고    scopus 로고
    • Molecular targeting and gene delivery in bladder cancer therapy
    • Voutsinas GE, Stravopodis DJ. Molecular targeting and gene delivery in bladder cancer therapy. J BUON 2009, 14(Suppl 1):S69-78.
    • (2009) J BUON , vol.14 , Issue.SUPPL. 1
    • Voutsinas, G.E.1    Stravopodis, D.J.2
  • 20
    • 77956476510 scopus 로고    scopus 로고
    • 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
    • 10.1186/1471-2407-10-481, 2944179, 20828379
    • Karkoulis PK, Stravopodis DJ, Margaritis LH, Voutsinas GE. 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells. BMC Cancer 2010, 10:481. 10.1186/1471-2407-10-481, 2944179, 20828379.
    • (2010) BMC Cancer , vol.10 , pp. 481
    • Karkoulis, P.K.1    Stravopodis, D.J.2    Margaritis, L.H.3    Voutsinas, G.E.4
  • 22
    • 17144377442 scopus 로고    scopus 로고
    • Hsp90 activation and cell cycle regulation
    • 10.4161/cc.3.12.1277, 15539946
    • Burrows F, Zhang H, Kamal A. Hsp90 activation and cell cycle regulation. Cell Cycle 2004, 3(12):1530-1536. 10.4161/cc.3.12.1277, 15539946.
    • (2004) Cell Cycle , vol.3 , Issue.12 , pp. 1530-1536
    • Burrows, F.1    Zhang, H.2    Kamal, A.3
  • 24
    • 70350092520 scopus 로고    scopus 로고
    • Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
    • 10.1186/1476-4598-8-68, 2741463, 19715609
    • Mediavilla-Varela M, Pacheco FJ, Almaguel F, Perez J, Sahakian E, Daniels TR, Leoh LS, Padilla A, Wall NR, Lilly MB. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer 2009, 8(1):68. 10.1186/1476-4598-8-68, 2741463, 19715609.
    • (2009) Mol Cancer , vol.8 , Issue.1 , pp. 68
    • Mediavilla-Varela, M.1    Pacheco, F.J.2    Almaguel, F.3    Perez, J.4    Sahakian, E.5    Daniels, T.R.6    Leoh, L.S.7    Padilla, A.8    Wall, N.R.9    Lilly, M.B.10
  • 25
    • 70349479251 scopus 로고    scopus 로고
    • Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell death
    • 10.1158/1541-7786.MCR-08-0542, 19723872
    • Byun JY, Kim MJ, Yoon CH, Cha H, Yoon G, Lee SJ. Oncogenic Ras signals through activation of both phosphoinositide 3-kinase and Rac1 to induce c-Jun NH2-terminal kinase-mediated, caspase-independent cell death. Mol Cancer Res 2009, 7(9):1534-1542. 10.1158/1541-7786.MCR-08-0542, 19723872.
    • (2009) Mol Cancer Res , vol.7 , Issue.9 , pp. 1534-1542
    • Byun, J.Y.1    Kim, M.J.2    Yoon, C.H.3    Cha, H.4    Yoon, G.5    Lee, S.J.6
  • 26
    • 0141484615 scopus 로고    scopus 로고
    • A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
    • 10.1038/nature01913, 14508491
    • Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425(6956):407-410. 10.1038/nature01913, 14508491.
    • (2003) Nature , vol.425 , Issue.6956 , pp. 407-410
    • Kamal, A.1    Thao, L.2    Sensintaffar, J.3    Zhang, L.4    Boehm, M.F.5    Fritz, L.C.6    Burrows, F.J.7
  • 27
    • 79952440468 scopus 로고    scopus 로고
    • Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis
    • 10.1007/s10620-010-1294-2, 20585984
    • Redlak MJ, Miller TA. Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis. Dig Dis Sci 2011, 56(2):323-329. 10.1007/s10620-010-1294-2, 20585984.
    • (2011) Dig Dis Sci , vol.56 , Issue.2 , pp. 323-329
    • Redlak, M.J.1    Miller, T.A.2
  • 28
    • 84055190677 scopus 로고    scopus 로고
    • Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy
    • 10.4161/cc.10.24.18616, 22134243
    • Yoshida S, Koga F, Tatokoro M, Kawakami S, Fujii Y, Kumagai J, Neckers L, Kihara K. Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy. Cell Cycle 2011, 10(24):4291-4299. 10.4161/cc.10.24.18616, 22134243.
    • (2011) Cell Cycle , vol.10 , Issue.24 , pp. 4291-4299
    • Yoshida, S.1    Koga, F.2    Tatokoro, M.3    Kawakami, S.4    Fujii, Y.5    Kumagai, J.6    Neckers, L.7    Kihara, K.8
  • 29
    • 2142759556 scopus 로고    scopus 로고
    • Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis
    • Brader S, Eccles SA. Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumorigenesis 2004, 90(1):2-8.
    • (2004) Tumorigenesis , vol.90 , Issue.1 , pp. 2-8
    • Brader, S.1    Eccles, S.A.2
  • 30
    • 77954675751 scopus 로고    scopus 로고
    • Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
    • 10.1186/1750-2187-5-10, 2915986, 20642839
    • Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 2010, 5:10. 10.1186/1750-2187-5-10, 2915986, 20642839.
    • (2010) J Mol Signal , vol.5 , pp. 10
    • Roy, S.K.1    Srivastava, R.K.2    Shankar, S.3
  • 32
    • 34547697832 scopus 로고    scopus 로고
    • Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells
    • 10.4161/cc.6.11.4296, 17525527
    • Koga F, Tsutsumi S, Neckers LM. Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells. Cell Cycle 2007, 6(11):1393-1402. 10.4161/cc.6.11.4296, 17525527.
    • (2007) Cell Cycle , vol.6 , Issue.11 , pp. 1393-1402
    • Koga, F.1    Tsutsumi, S.2    Neckers, L.M.3
  • 33
    • 0029056501 scopus 로고
    • Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
    • 10.1007/BF00689048, 7628050
    • Supko JG, Hickman RL, Grever MR, Malspeis L. Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol 1995, 36(4):305-315. 10.1007/BF00689048, 7628050.
    • (1995) Cancer Chemother Pharmacol , vol.36 , Issue.4 , pp. 305-315
    • Supko, J.G.1    Hickman, R.L.2    Grever, M.R.3    Malspeis, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.